Jones Trading Upgrades Capricor Therapeutics to Buy, Announces $25 Price Target

Benzinga · 1d ago
Jones Trading analyst Catherine Novack upgrades Capricor Therapeutics (NASDAQ:CAPR) from Hold to Buy and announces $25 price target.